PATIENT-REPORTED AND QUALITY OF LIFE OUTCOMES FROM MYCARING, A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, PHASE 3 TRIAL OF ROZANOLIXIZUMAB IN GENERALISED MYASTHENIA GRAVIS

被引：0
|
作者：
Habib, Ali A. [1 ]
Druzdz, Artur [2 ]
Grosskreutz, Julian [3 ]
Kaminski, Henry [4 ]
Mantegazza, Renato [5 ]
Sacconi, Sabrina [6 ]
Utsugisawa, Kimiaki [7 ]
Vissing, John [8 ]
Vu, Tuan [9 ]
Morel, Thomas [10 ]
Boehnlein, Marion [11 ]
Woltering, Franz [11 ]
Bozorg, Ali [12 ]
Gayfieva, Maryam [13 ]
Bril, Vera [14 ]
机构：
[1] Univ Calif Irvine, Orange, CA 92668 USA
[2] Municipal Hosp Poznan, Poznan, Poland
[3] Univ Lubeck, Lubeck, Germany
[4] George Washington Univ, Med Ctr, Washington, DC 20037 USA
[5] Fdn IRCCS Ist Neurol Carlo Besta, Milan, Italy
[6] CHU Nice, Nice, France
[7] Hanamaki Gen Hosp, Hanamaki, Japan
[8] Univ Copenhagen, Rigshosp, Copenhagen, Denmark
[9] Univ S Florida, Morsani Coll Med, Tampa, FL 33620 USA
[10] UCB Pharma, Brussels, Belgium
[11] UCB Pharma, Monheim, Germany
[12] UCB Pharma, Morrisville, NC USA
[13] UCB Pharma, Slough, Berks, England
[14] Univ Hlth Network, Toronto, ON, Canada
来源：
MUSCLE & NERVE | 2022年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S19 / S20
页数：2
相关论文
共 50 条
  • [41] The short-term impact of methylprednisolone on patient-reported sleep in patients with advanced cancer in a randomized, placebo-controlled, double-blind trial
    Gunnhild Jakobsen
    Morten Engstrøm
    Marianne Jensen Hjermstad
    Jan Henrik Rosland
    Nina Aass
    Eva Albert
    Stein Kaasa
    Peter Fayers
    Pål Klepstad
    Ørnulf Paulsen
    [J]. Supportive Care in Cancer, 2021, 29 : 2047 - 2055
  • [42] Effect of Atogepant for Preventive Migraine Treatment on Patient-Reported Outcomes in the Randomized, Double-blind, Phase 3 ADVANCE Trial
    Lipton, Richard B.
    Pozo-Rosich, Patricia
    Blumenfeld, Andrew M.
    Li, Ye
    Severt, Lawrence
    Stokes, Jonathan T.
    Creutz, Lela
    Gandhi, Pranav
    Dodick, David
    [J]. NEUROLOGY, 2023, 100 (08) : E764 - E777
  • [43] Effect of a multivitamin and mineral supplement on infection and quality of life - A randomized, double-blind, placebo-controlled trial
    Barringer, TA
    Kirk, JK
    Santaniello, AC
    Foley, KL
    Michielutte, R
    [J]. ANNALS OF INTERNAL MEDICINE, 2003, 138 (05) : 365 - 371
  • [44] Rupatadine treatment improves quality of life in patients with mastocytosis: a randomized, double-blind, placebo-controlled trial
    Siebenhaar, F.
    Foertsch, A.
    Maurer, M.
    [J]. EXPERIMENTAL DERMATOLOGY, 2013, 22 (03) : E12 - E12
  • [45] Marfan Sartan: a randomized, double-blind, placebo-controlled trial
    Milleron, Olivier
    Arnoult, Florence
    Ropers, Jacques
    Aegerter, Philippe
    Detaint, Delphine
    Delorme, Gabriel
    Attias, David
    Tubach, Florence
    Dupuis-Girod, Sophie
    Plauchu, Henry
    Barthelet, Martine
    Sassolas, Francois
    Pangaud, Nicolas
    Naudion, Sophie
    Thomas-Chabaneix, Julie
    Dulac, Yves
    Edouard, Thomas
    Wolf, Jean-Eric
    Faivre, Laurence
    Odent, Sylvie
    Basquin, Adeline
    Habib, Gilbert
    Collignon, Patrick
    Boileau, Catherine
    Jondeau, Guillaume
    [J]. EUROPEAN HEART JOURNAL, 2015, 36 (32) : 2160 - U37
  • [46] A randomized, double-blind, placebo-controlled trial of pseudoephedrine in coryza
    Latte, J
    Taverner, D
    Slobodian, P
    Shakib, S
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2004, 31 (07): : 429 - 432
  • [47] A double-blind, randomized, placebo-controlled laser trial methodology
    Oussedik, E.
    Saleem, M. D.
    Patel, N. U.
    Feldman, S. R.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (10) : B11 - B11
  • [48] Effect of Ruxolitinib Therapy on Myelofibrosis-Related Symptoms and Other Patient-Reported Outcomes in COMFORT-I: A Randomized, Double-Blind, Placebo-Controlled Trial
    Mesa, Ruben A.
    Gotlib, Jason
    Gupta, Vikas
    Catalano, John V.
    Deininger, Michael W.
    Shields, Alan L.
    Miller, Carole B.
    Silver, Richard T.
    Talpaz, Moshe
    Winton, Elliott F.
    Harvey, Jimmie H.
    Hare, Thomas
    Erickson-Viitanen, Susan
    Sun, William
    Sandor, Victor
    Levy, Richard S.
    Kantarjian, Hagop M.
    Verstovsek, Srdan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (10) : 1285 - 1292
  • [49] KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive Dyskinesia
    Hauser, Robert A.
    Factor, Stewart A.
    Marder, Stephen R.
    Knesevich, Mary Ann
    Ramirez, Paul M.
    Jimenez, Roland
    Burke, Joshua
    Liang, Grace S.
    O'Brien, Christopher F.
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2017, 174 (05): : 476 - 484
  • [50] Patient-Reported Outcomes from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar(R) Gel) for Persistently Active Systemic Lupus Erythematosus
    Askanase, Anca D.
    Wan, George J.
    Panaccio, Mary P.
    Zhao, Enxu
    Zhu, Julie
    Bilyk, Roman
    Furie, Richard A.
    [J]. RHEUMATOLOGY AND THERAPY, 2021, 8 (01) : 573 - 584
12345